Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 10, 2023

BUY
$4.08 - $8.14 $4,541 - $9,059
1,113 Added 83.62%
2,444 $11,000
Q2 2023

Jul 26, 2023

BUY
$4.04 - $5.47 $1,337 - $1,810
331 Added 33.1%
1,331 $5,000
Q3 2022

Oct 13, 2022

SELL
$5.34 - $12.79 $13,350 - $31,974
-2,500 Reduced 71.43%
1,000 $10,000
Q2 2022

Jul 28, 2022

BUY
$5.1 - $9.74 $17,850 - $34,090
3,500 New
3,500 $19,000

Others Institutions Holding CRBU

About Caribou Biosciences, Inc.


  • Ticker CRBU
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 60,840,800
  • Market Cap $133M
  • Description
  • Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally. Its lead product candidates are CB-010, an allogeneic anti-CD19 CAR-T cell therapy that is in phase 1...
More about CRBU
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.